3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Obesity
1
Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Interventions
Vitamin D
2
Tirzepatide
2
Metformin
2
licogliflozin
1
indole-3-carbinol
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Tablets
1
Specimen Handling
1
Resistance Training
1
Progestins
1
Pregabalin
1
Orlistat
1
Organizational Objectives
1
Omeprazole
1
Observation
1
Naltrexone
1
Ketorolac
1
Exergaming
1
Exercise
1
Exenatide
1
Diet, Plant-Based
1
Dexmedetomidine
1
Dalteparin
1
Counseling
1
Cholecalciferol
1
Calcium Citrate
1
Calcium Carbonate
1
Calcitriol
1
CKD732
1
Bupropion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Obesity
×
Organizational Objectives
×
Clear all
NCT01004094
2016-01-20
SQ!II
Baylor College of Medicine
Phase 2
Completed
800 enrolled